potassium chloride has been researched along with Migraine Disorders in 19 studies
Potassium Chloride: A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA.
potassium chloride : A metal chloride salt with a K(+) counterion.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oxcarbazepine did not suppress spreading depression either after a single dose or after daily treatment for 5 weeks." | 1.37 | Oxcarbazepine does not suppress cortical spreading depression. ( Ayata, C; Dileköz, E; Hoffmann, U; Kudo, C, 2011) |
| "The S218L mutants also develop coma and seizures and sometimes die." | 1.37 | Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice. ( Ayata, C; Baek, K; Dilekoz, E; Eikermann-Haerter, K; Ferrari, MD; Hoffmann, U; Kim, YR; Moskowitz, MA; Qin, T; van den Maagdenberg, AM; Waeber, C; Wang, Y; Yuzawa, I, 2011) |
| "Migraine is one of the risk factor for ischemic stroke." | 1.37 | Neuroprotection by lomerizine, a prophylactic drug for migraine, against hydrogen peroxide-induced hippocampal neurotoxicity. ( Iizuka, R; Ishii, M; Kiuchi, Y; Mori, Y; Shimizu, S, 2011) |
| "The prevalence of migraine is higher in women than in men, and changes in 17beta-estradiol levels seem to affect the frequency of attacks in female migraineurs." | 1.34 | Rat carotid artery responses to alpha-adrenergic receptor agonists and 5-HT after ovariectomy and hormone replacement. ( Boomsma, F; Gupta, S; MaassenVanDenbrink, A; Mehrotra, S; Saxena, PR; Villalón, CM, 2007) |
| "The prevalence of migraine is much greater in female than male individuals." | 1.34 | Reduced threshold for cortical spreading depression in female mice. ( Arnold, AP; Brennan, KC; Charles, AC; López Valdés, HE; Romero Reyes, M, 2007) |
| "Migraine headache is proposed to be mediated by nitric oxide (NO)." | 1.31 | Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan. ( Hirst, WD; Parsons, AA; Read, SJ; Upton, N, 2001) |
| "Although the recurrent headache of migraine is of unknown origin and is not accompanied by an identifiable pathology, it shares with intracranial headaches features that suggest an exaggerated intracranial mechanosensitivity (worsening of the pain by coughing, breath-holding or sudden head movement)." | 1.29 | Sensitization of meningeal sensory neurons and the origin of headaches. ( Burstein, R; Raymond, SA; Strassman, AM, 1996) |
| "The pathophysiology of migraine is still poorly understood but it is widely accepted that various 'triggers', including fluctuations in the concentrations of circulating ovarian steroid levels, may initiate alterations in the activity of the intracranial vasculature and its efferent and afferent innervation." | 1.28 | New possibilities for anti-migraine drugs: prostanoid antagonists and progesterone-mimicking stabilizers of excitable cells. ( Leathard, HL, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 10 (52.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurauchi, Y | 1 |
| Haruta, M | 1 |
| Tanaka, R | 1 |
| Sasagawa, K | 1 |
| Ohta, J | 1 |
| Hisatsune, A | 1 |
| Seki, T | 1 |
| Katsuki, H | 1 |
| Saengjaroentham, C | 1 |
| Supornsilpchai, W | 1 |
| Ji-Au, W | 1 |
| Srikiatkhachorn, A | 1 |
| Maneesri-le Grand, S | 1 |
| Hoffmann, J | 1 |
| Supronsinchai, W | 1 |
| Akerman, S | 1 |
| Andreou, AP | 1 |
| Winrow, CJ | 1 |
| Renger, J | 1 |
| Hargreaves, R | 1 |
| Goadsby, PJ | 1 |
| Alabwah, Y | 1 |
| Ji, Y | 1 |
| Seminowicz, DA | 1 |
| Quiton, RL | 1 |
| Masri, R | 1 |
| Bogdanov, VB | 2 |
| Middleton, NA | 1 |
| Theriot, JJ | 1 |
| Parker, PD | 1 |
| Abdullah, OM | 1 |
| Ju, YS | 1 |
| Hartings, JA | 1 |
| Brennan, KC | 3 |
| Noseda, R | 1 |
| Constandil, L | 1 |
| Bourgeais, L | 1 |
| Chalus, M | 1 |
| Villanueva, L | 1 |
| Hoffmann, U | 2 |
| Dileköz, E | 2 |
| Kudo, C | 1 |
| Ayata, C | 2 |
| Eikermann-Haerter, K | 1 |
| Yuzawa, I | 1 |
| Qin, T | 1 |
| Wang, Y | 1 |
| Baek, K | 1 |
| Kim, YR | 1 |
| Waeber, C | 1 |
| Ferrari, MD | 1 |
| van den Maagdenberg, AM | 1 |
| Moskowitz, MA | 1 |
| Ishii, M | 1 |
| Iizuka, R | 1 |
| Kiuchi, Y | 1 |
| Mori, Y | 1 |
| Shimizu, S | 1 |
| Bogdanova, OV | 1 |
| Koulchitsky, SV | 1 |
| Chauvel, V | 1 |
| Multon, S | 1 |
| Makarchuk, MY | 1 |
| Renshaw, PF | 1 |
| Schoenen, J | 1 |
| Gorji, A | 1 |
| Zahn, PK | 1 |
| Pogatzki, EM | 1 |
| Speckmann, EJ | 1 |
| Mehrotra, S | 1 |
| Gupta, S | 1 |
| Villalón, CM | 1 |
| Boomsma, F | 1 |
| Saxena, PR | 1 |
| MaassenVanDenbrink, A | 1 |
| Romero Reyes, M | 1 |
| López Valdés, HE | 1 |
| Arnold, AP | 1 |
| Charles, AC | 1 |
| Peroutka, SJ | 1 |
| Allen, GS | 1 |
| Richter, F | 1 |
| Lehmenkühler, A | 1 |
| Strassman, AM | 1 |
| Raymond, SA | 1 |
| Burstein, R | 1 |
| Smith, MI | 1 |
| Read, SJ | 2 |
| Chan, WN | 1 |
| Thompson, M | 1 |
| Hunter, AJ | 1 |
| Upton, N | 2 |
| Parsons, AA | 2 |
| Hirst, WD | 1 |
| Leathard, HL | 1 |
19 other studies available for potassium chloride and Migraine Disorders
| Article | Year |
|---|---|
Propranolol prevents cerebral blood flow changes and pain-related behaviors in migraine model mice.
Topics: Adrenergic beta-Antagonists; Animals; Cerebrovascular Circulation; Cortical Spreading Depression; Di | 2019 |
Serotonin depletion can enhance the cerebrovascular responses induced by cortical spreading depression via the nitric oxide pathway.
Topics: Analysis of Variance; Animals; Cerebrovascular Circulation; Cortical Spreading Depression; Disease M | 2015 |
Evidence for orexinergic mechanisms in migraine.
Topics: Animals; Azepines; Benzimidazoles; Central Nervous System Agents; Cortical Spreading Depression; Dis | 2015 |
Alcohol-triggered signs of migraine: An animal model.
Topics: Alcohols; Analysis of Variance; Animals; Avoidance Learning; Conditioning, Psychological; Disease Mo | 2016 |
Susceptibility of Primary Sensory Cortex to Spreading Depolarizations.
Topics: Animals; Brain Injuries; Cortical Spreading Depression; Humans; Ketamine; Male; Mice; Mice, Inbred C | 2016 |
Changes of meningeal excitability mediated by corticotrigeminal networks: a link for the endogenous modulation of migraine pain.
Topics: Animals; Biotin; Cerebral Cortex; Cortical Spreading Depression; Electric Stimulation; Immunohistoch | 2010 |
Oxcarbazepine does not suppress cortical spreading depression.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Cortical Spreading Depression; Electric Stimulation; | 2011 |
Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice.
Topics: Animals; Animals, Genetically Modified; Cardiovascular Physiological Phenomena; Cerebellar Ataxia; C | 2011 |
Neuroprotection by lomerizine, a prophylactic drug for migraine, against hydrogen peroxide-induced hippocampal neurotoxicity.
Topics: Animals; Benzamides; Calcium; Calcium Channel Blockers; Cell Death; Cells, Cultured; HEK293 Cells; H | 2011 |
Behavior in the open field predicts the number of KCl-induced cortical spreading depressions in rats.
Topics: Animals; Antimanic Agents; Anxiety; Behavior, Animal; Cortical Spreading Depression; Electrodes, Imp | 2013 |
Spinal and cortical spreading depression enhance spinal cord activity.
Topics: Action Potentials; Animals; Cortical Spreading Depression; In Vitro Techniques; Migraine Disorders; | 2004 |
Rat carotid artery responses to alpha-adrenergic receptor agonists and 5-HT after ovariectomy and hormone replacement.
Topics: Adrenergic alpha-Agonists; Animals; Carotid Arteries; Epinephrine; Estradiol; Female; Imidazoles; Mi | 2007 |
Reduced threshold for cortical spreading depression in female mice.
Topics: Animals; Cortical Spreading Depression; Disease Models, Animal; Dose-Response Relationship, Drug; El | 2007 |
The calcium antagonist properties of cyproheptadine: implications for antimigraine action.
Topics: Animals; Basilar Artery; Calcium Channel Blockers; Calcium Chloride; Cyproheptadine; Dogs; Female; M | 1984 |
Spreading depression can be restricted to distinct depths of the rat cerebral cortex.
Topics: Animals; Cerebral Cortex; Cortical Spreading Depression; Male; Migraine Disorders; Potassium Chlorid | 1993 |
Sensitization of meningeal sensory neurons and the origin of headaches.
Topics: Animals; Autacoids; Capsaicin; Dura Mater; Electric Stimulation; Electrophysiology; Headache; Hydrog | 1996 |
Repetitive cortical spreading depression in a gyrencephalic feline brain: inhibition by the novel benzoylamino-benzopyran SB-220453.
Topics: Analgesics; Animals; Anticonvulsants; Benzamides; Benzopyrans; Cats; Cortical Spreading Depression; | 2000 |
Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan.
Topics: Analgesics; Animals; Benzamides; Benzopyrans; Brain Stem; Cerebral Cortex; Cortical Spreading Depres | 2001 |
New possibilities for anti-migraine drugs: prostanoid antagonists and progesterone-mimicking stabilizers of excitable cells.
Topics: Arteries; Brain; Estradiol; Humans; Mefenamic Acid; Migraine Disorders; Muscle, Smooth, Vascular; Ne | 1989 |